Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network-Reference-Cited by-同舟云学术

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network

Published:2024-05 Issue:10441 Volume:403 Page:2293-2306
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Dreyling Martin,Doorduijn Jeanette,Giné Eva,Jerkeman Mats,Walewski Jan,Hutchings Martin,Mey Ulrich,Riise Jon,Trneny Marek,Vergote Vibeke,Shpilberg Ofer,Gomes da Silva Maria,Leppä Sirpa,Jiang Linmiao,Stilgenbauer Stephan,Kerkhoff Andrea,Jachimowicz Ron D,Celli Melania,Hess Georg,Arcaini Luca,Visco Carlo,van Meerten Tom,Wirths Stefan,Zinzani Pier Luigi,Novak Urban,Herhaus Peter,Benedetti Fabio,Sonnevi Kristina,Hanoun Christine,Hänel Matthias,Dierlamm Judith,Pott Christiane,Klapper Wolfram,Gözel Döndü,Schmidt Christian,Unterhalt Michael,Ladetto Marco,Hoster Eva

Publisher

Elsevier BV

Reference30 articles.

1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee;Campo;Blood,2022

2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms;Alaggio;Leukemia,2022

3. Outcome of deferred initial therapy in mantle-cell lymphoma;Martin;J Clin Oncol,2009

4. Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!;Dreyling;Blood,2018

5. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma;Hoster;Blood,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. More is not always better;Blood;2024-09-05

2. Accessing BTK Inhibitors and Other Novel Therapies for Mantle Cell Lymphoma: Are We All Invited to the Party?;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Sequencing Therapies in Relapsed/Refractory Mantle Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-09

4. BTKi is better: a lesson learned?;Blood;2024-08-29

5. New and developing first line pharmacotherapies for treating non-Hodgkin lymphoma;Expert Opinion on Pharmacotherapy;2024-08-12